DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/d9793d/pharmatec_pakistan) has announced the addition of the "Pharmatec Pakistan (private) Limited-Detailed Product Pipeline" company profile to their offering.
Pharmatec Pakistan (private) Limited-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.
Scope of the reports
Each Pipeline Report provides the user with real detail on a companys pipeline.
In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a companys product pipeline and disease hub classification.
Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a companys deals and alliances and recent corporate news including key milestones.
Key benefits
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a companys research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.
Key Topics Covered:
- Business Summary
- Product Glance
- Products by Phase of Development
- Products by Disease Hub Classification
- Products by Indication
- Product Summary
- Product Details
For more information visit http://www.researchandmarkets.com/research/d9793d/pharmatec_pakistan
Source: Life Science Analytics
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
Email 
